@ElixirMed

Innovation for Life. Elixir Medical is committed to transforming care for patients with heart and vascular disease through innovation.

elixirmedical.com
Joined July 2015
  • Tweets462
  • Following4.7K
  • Followers1.9K
375Media
Elixir Medical Corp retweeted
Elixir Medical Corp
@ElixirMed17 May 2023
New 12-month DynamX Bioadaptor clinical data show statistically significant effectiveness compared to DES in the BIOADAPTOR RCT trial. View the full results: dynamXbioadaptor.com. #CardioTwitter #EuroPCR *CE marked. Not approved in the U.S.
6
2
11
843
Elixir Medical Corp retweeted
Vinayak Bhat, PhD@vinayakdbhat17 May 2023
A team from Elixir will be at the EuroPCR to answer any questions about the latest innovation to treat your CAD patients after the release of the Late Breaking Clinical trial results from Bioadaptor Radomized clinical trial by Dr. Saito! #bioadaptor #elixirmedical
1
4
1
9
903
Elixir Medical Corp retweeted
PCRonline 🫀
@PCRonline17 May 2023
In a trial of patients undergoing #PCI, a novel sirolimus-eluting bioadaptor scaffold was non-inferior in target lesion failure compared with a zotarolimus-eluting DES, had lower lumen loss, and restored pulsatility at 12 months #EuroPCR
2
20
9
50
16,794
Elixir Medical Corp retweeted
Elixir Medical Corp
@ElixirMed3 May 2023
Attending #EuroPCR 2023? Join us to learn more about the primary endpoint outcomes of the DynamX BIOADAPTOR RCT, comparing DynamX Bioadaptor to Resolute Onyx (n=445). tinyurl.com/3tcfr4xp #CardioTwitter #medtech *CE marked. Not approved in the US
5
1
6
3,898
Elixir Medical Corp retweeted
Damiano Regazzoli@DamianoRegazzo19 Nov 2022
Happy operators, happy patient! @beavaquerizo, @sjorge4 and @AntonioMangieri provided best in class rotational Atherectomy followed by DCB (@conceptmedicals MagicTouch) and brand new DES (@ElixirMed DynamX)! IVUS by @ChadiGhafari. Challenging cases from @tobicongress 2022!
5
2
31
Elixir Medical Corp retweeted
Ziyad HIJAZI@structuralheart9 Oct 2022
Just got back from SF after I used an innovative implant developed by Elixir Medical in a preclinical study to repair Mitral valve regurgitation with excellent results and reduction in mitral annulus area.
4
14
3
66
Elixir Medical Corp retweeted
Mladen Vidovich@mividovich19 Sep 2022
About to present coronary rotation and stent "uncaging" data for the DynamX™ Coronary Bioadaptor System 👉🏻Pretty awesome new technology to address physiologic coronary motion @ElixirMed @TCTMD #TCT2022 @mmkansal - Emerging Clinical Science & Research Station 1
13
1
36
Elixir Medical Corp retweeted
Cardiology Today@CardiologyToday7 Jun 2022
ICYMI: "We found that, after the bioadaptor uncaged over 6 months, the device significantly improved coronary rotation in the treated segment of their arteries.” @CRMjournal @mividovich @ChicagoVAMC #CardioTwitter healio.com/news/cardiac-vasc…
6
1
11
@DAICeditor @ElixirMed Trial evaluates #DynamX Coronary #Bioadaptor System, the first #drug_eluting #coronary #artery implant that adapts to vessel physiology, allowing for the restoration of normal vessel functions essential to cardiovascular performance: dicardiology.com/content/eli…

Elixir Medical Completes Enrollment in Bioadaptor Randomized Controlled Trial of DynamX Coronary...

February 16, 2022 – Elixir Medical, a developer of innovative, drug-eluting cardiovascular devices, has announced completion of enrollment in the BIOADAPTOR randomized controlled trial (RCT). The...

dicardiology.com
1
2
Elixir Medical Corp retweeted
Erik Rafflenbeul@KardiologieHH8 Apr 2021
Thread on the 🔥talk by @HolgerNef on: ➡️Future perspectives in interventional Cardiology (#IC) - The next 5 years...a lot to come - #DGKJahrestagung 2021 @AGIKinterv
2
8
1
33
Elixir Medical Corp retweeted
Erik Rafflenbeul@KardiologieHH8 Apr 2021
15/ #HybridDES ➡️Twelve-month clinical and imaging outcomes of the uncaging coronary DynamX bioadaptor system Data by Stefan Verheye: eurointervention.pcronline.c… #DGKJahrestagung 2021 @AGIKinterv
1
6
2
8
Elixir Medical Begins BIOADAPTOR Trial of DynamX System | @ElixirMed citoday.com/news/elixir-medi…
3
4
Twelve-Month Data Presented for Elixir Medical (@ElixirMed) DynamX Bioadaptor System Presented by Stefan Verheye, MD, at @PCRonline Late-Breaking Trials session citoday.com/news/twelve-mont…

Twelve-Month Data Presented for Elixir Medical’s DynamX Bioadaptor System - Cardiac Interventions...

June 25, 2020—Elixir Medical announced the presentation of 12-month data for the DynamX coronary bioadaptor system online as part of the Late-Br

citoday.com
1
2
3
infomeddnews.com/elixir-medi…
1
1
2
Elixir Medical Corp retweeted
TCTMD
@TCTMD22 May 2020
Kenneth Kent, Angioplasty Pioneer and Original TCT Co-Director, Dies at 81 dlvr.it/RX9fMk
2
5
1
18
Load more